简介：
Overview
This study develops rodent models to replicate gender-affirming hormone therapies for transgender individuals, utilizing testosterone for transgender men and estrogen with anti-androgen for transgender women. It evaluates the long-term effects of these therapies and their interactions with environmental chemicals.
Key Study Components
Research Area
- Gender-affirming hormone therapies
- Transgender health research
- Impact of environmental chemicals
Background
- Need for understanding the long-term effects of hormone treatments
- Gap in knowledge regarding vulnerability to environmental chemicals
- Development of sex-specific biomarkers to assess therapy impact
Methods Used
- Subcutaneous administration of testosterone and estradiol plus cyproterone acetate
- Rodent model system
- Use of hepatic CPS as a biomarker
Main Results
- Development of a unique animal model for evaluating hormone therapies
- Significant findings regarding the potential susceptibility of transgender individuals to environmental chemicals
- Establishment of sex-specific markers to validate therapy success
Conclusions
- The study provides insights into the long-term effects of gender-affirming hormone therapies and their interactions with environmental factors.
- Findings are relevant for enhancing understanding of transgender health and safety.
What is the primary focus of this research?
The research focuses on developing rodent models to study gender-affirming hormone therapies and their long-term effects on transgender health.
Why are rodent models used in this study?
Rodent models provide an essential system to investigate the biological effects of hormone therapies and potential interactions with environmental chemicals.
What hormones are administered to the rodent models?
Testosterone for transgender men and estrogen with cyproterone acetate for transgender women are administered in the study.
What is the significance of using sex-specific biomarkers?
Sex-specific biomarkers help assess the accuracy and effectiveness of hormone therapies, providing valuable data on treatment success.
How does this research contribute to transgender health?
It addresses gaps in understanding the long-term effects of hormone therapies and their interactions with environmental factors, which is crucial for improving care for transgender individuals.
What future research directions are proposed?
Future studies will explore long-term testing suitability and investigate additional biomarkers to enhance therapy effect assessment.
繁體中文
